SPIDY yields 5.36% · JNJ yields 2.13%● Live data
📍 SPIDY pulled ahead of the other in Year 1
Combined, SPIDY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SPIDY + JNJ for your $10,000?
Septeni Holdings Co., Ltd., through its subsidiaries, engages in the digital marketing and media platform businesses in Japan and internationally. The company provides cloud-based CRM and smartphone advertising services. It also cultivates and produces Manga artists and distributes Manga works online. In addition, the company operates ViViViT, a matching-type recruitment platform that matches companies with students aspiring to be IT engineers and web designers; gooddo, a social contribution platform; and Pharmarket, a platform through which it purchases immobile stock from dispensary pharmacies and sells it on to other pharmacies. Further, it provides incubation support services that foster and cultivate new businesses from the initial creation stages. The company was formerly known as Septeni Co., Ltd. and changed its name to Septeni Holdings Co., Ltd. in October 2006. Septeni Holdings Co., Ltd. was incorporated in 1990 and is headquartered in Tokyo, Japan.
Full SPIDY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.